Global Human Cytomegalovirus Envelope Glycoprotein B (gB) Market Pipeline Review, H2 2017
Human Cytomegalovirus Envelope B(gB)
Overview
Human Cytomegalovirus Envelope Glycoprotein B (gB) pipeline Target constitutes close to 10 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes.
The latest report Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2017, outlays comprehensive information on the Human Cytomegalovirus Envelope Glycoprotein B (gB) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2574814-human-cytomegalovirus-envelope-glycoprotein-b-gb-pipeline-review-h2-2017
Major Key Players:
Astellas Pharma Inc
Merck & Co Inc
Novartis AG
Trellis Bioscience Inc
Vakzine Projekt Management GmbH
VBI Vaccines Inc
Vical Inc
Major Highlight
Pharmaceutical and Healthcare latest pipeline guide Human Cytomegalovirus Envelope - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Human Cytomegalovirus Envelope , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Human Cytomegalovirus Envelope Glycoprotein B (gB) - Human Cytomegalovirus envelope glycoprotein B plays an important role in host cell entry and cell to cell virus transmission. It is involved in the initial attachment via binding to heparan sulfate together with the gM/gN complex that binds heparin with higher affinity. It interacts with host integrin ITGB1, PDGFRA and EGFR that likely serve as post attachment entry receptors. It participates in the fusion of viral and cellular membranes leading to virus entry into the host cell. The molecules developed by companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 1, 2, 3 and 1 respectively.
Human Cytomegalovirus Envelope pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2574814-human-cytomegalovirus-envelope-glycoprotein-b-gb-pipeline-review-h2-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Posted by
Vivian Dsena
on Wednesday April 04 2018, 7:11 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
